Scinai Immunotherapeutics (SCNI) Debt Ratio (2018 - 2026)

Scinai Immunotherapeutics has disclosed Debt Ratio across 9 years of filings, most recently posting 0.02 for Q2 2026.

• In Q2 2026, Debt Ratio fell 32.94% year-over-year to 0.02; the TTM figure through Jun 2026 stood at 0.02 (down 32.94% YoY), while the FY2025 annual figure was 0.6, down 3193.33% from the prior year.
• Debt Ratio came in at 0.02 for Q2 2026 at Scinai Immunotherapeutics, up from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.33 in Q2 2024 to a low of 0.6 in Q4 2025.
• Average Debt Ratio over 5 years is 0.48, with a median of 0.22 recorded in 2022.
• Year-over-year, Debt Ratio surged 8587.53% in 2023 and plunged 3193.33% in 2025.
• Over 5 years, Debt Ratio stood at 0.77 in 2022, then jumped by 43.93% to 1.11 in 2023, then tumbled by 98.26% to 0.02 in 2024, then plunged by 3193.33% to 0.6 in 2025, then surged by 102.77% to 0.02 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.02 in Q2 2026, 0.02 in Q1 2026, and 0.6 in Q4 2025.